On average, we wait 867 days (approximately 2.5 years) for public coverage of certain blood cancer treatments. Fifteen other ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC).

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...

Cancer survivors can be a source of hope for others navigating life with cancer. Survivors include anyone who has been ...

Mayo Clinic researchers developed MedEduChat, an AI-powered EHR tool that delivers personalized prostate cancer education ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...

After undergoing surgery, reconstruction and radiation for breast cancer, the TODAY contributor must have another procedure ...

According to the World Health Organization, each year cervical cancer impacts approximately 600,000 women throughout the ...

Autonomix Medical is focused on developing precision nerve-targeted treatments using a transvascular RF denervation platform. The company’s approach aims to address pancreatic cancer pain, which ...

In an effort to extend financing support for patients seeking CAR-T cell therapy, Immuneel Therapeutics has partnered with healthcare crowdfunding platform Impact Guru, and healthcare-focussed lending ...